Skip to content
Steve Lenier

Steve Lenier

Contributing Writer

Steve Lenier began a career in medical literature over 30 years ago. He has worked on a variety of publications and projects, and across a number of specialties. Since 2005 most of his time has been spent covering ophthalmology, both print and online.

  • All
  • Deals
  • Devices and Diagnostics
  • Digital
  • Genetics
  • Pharma
Bausch, Clearside See Gains Post-Deal

Bausch, Clearside See Gains Post-Deal

When it comes to the stock market, Bausch Health’s has been rising steadily, up 4.1% in the past month, and on November 13 hit a ...
Read More
Private Financing Trends: Ophthalmology Ranks Tenth

Private Financing Trends: Ophthalmology Ranks Tenth

SAN FRANCISCO, Calif. — Almost $25 billion in venture funds have been raised in just the United States alone over the past 2.5 years to ...
Read More
Ain’t Misbehaving

Ain’t Misbehaving

What a difference a day (or so) makes. On Oct. 10, the day of the Ophthalmic Innovation Summit, Aerie Pharmaceuticals' stock closed at $17.72. The ...
Read More
What Has 50 Companies, Four Breakout Sessions, Winning Pitch Winners, and a Keynote Conversation? OIS@AAO 2019

What Has 50 Companies, Four Breakout Sessions, Winning Pitch Winners, and a Keynote Conversation? OIS@AAO 2019

SAN FRANCISCO — Winners of a “Shark Tank” style challenge in cataract/refractive and retina and specialty showcase sessions targeting four themes, including gene and cell ...
Read More
Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

LensGen CEO Ramgopal Rao says the company has been built around a laser focus on customers’ needs and wants. That led LensGen to identify a ...
Read More
5 Factors for Evaluating Investments in the Retina Space

5 Factors for Evaluating Investments in the Retina Space

As noted in a previous installment, innovators in the retina space sometimes utilize ex-US partnerships for financing the expensive process of taking drugs and devices ...
Read More
As Retina Innovators Look Outside US for Funding, Here’s What to Watch Out For

As Retina Innovators Look Outside US for Funding, Here’s What to Watch Out For

CHICAGO – As innovation in the retina space has grown over the past quarter century, so has the need for capital to finance those activities. ...
Read More
How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

In traditional cataract surgery, the surgeon removes the clouded natural lens and replaces it with a synthetic intraocular lens (IOL), placing it into the capsular ...
Read More
Recent Moves Show How Zeiss Is Positioning Itself for a New Era in Ophthalmology

Recent Moves Show How Zeiss Is Positioning Itself for a New Era in Ophthalmology

Carl Zeiss Meditec has made a series of strategic moves in recent weeks in glaucoma, retina, cataract, and refractive, along with reaching a milestone on ...
Read More
Ocular Therapeutix’s Strong Bounce Back

After Re-submitted NDA a Year Ago, Ocular Therapeutix Finds Its Path Forward

In July 2018 Ocular Therapeutix re-submitted its New Drug Application for Dextenza to the Food and Drug Administration. At that time, Scott Corning, the company’s ...
Read More
ASCRS 2019

Reporter’s ASCRS Notebook: Five Things in Dry Eye, MIGS, Imaging, and Mydriatics

SAN DIEGO – The 2019 meeting of the American Society of Cataract and Refractive Surgery is about a month in the rearview mirror, but these ...
Read More

Four Imaging and Diagnostic Platforms Making the Move Toward More Individualized Treatment

Imaging and diagnostics in ophthalmology are moving toward more individualized patient treatment, with quicker and more detailed diagnoses leading to improved and more specific treatment ...
Read More
Scroll To Top